nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C19—Memantine—Alzheimer's disease	0.147	0.28	CbGbCtD
Sitaxentan—CYP2C9—Donepezil—Alzheimer's disease	0.141	0.268	CbGbCtD
Sitaxentan—CYP3A4—Rivastigmine—Alzheimer's disease	0.102	0.195	CbGbCtD
Sitaxentan—CYP3A4—Donepezil—Alzheimer's disease	0.0817	0.156	CbGbCtD
Sitaxentan—CYP3A4—Galantamine—Alzheimer's disease	0.0527	0.101	CbGbCtD
Sitaxentan—Tension—Galantamine—Alzheimer's disease	0.000425	0.00115	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000423	0.00114	CcSEcCtD
Sitaxentan—Renal failure—Donepezil—Alzheimer's disease	0.000422	0.00114	CcSEcCtD
Sitaxentan—Myocardial infarction—Donepezil—Alzheimer's disease	0.000421	0.00114	CcSEcCtD
Sitaxentan—Nervousness—Galantamine—Alzheimer's disease	0.00042	0.00113	CcSEcCtD
Sitaxentan—Bronchitis—Memantine—Alzheimer's disease	0.00042	0.00113	CcSEcCtD
Sitaxentan—Jaundice—Donepezil—Alzheimer's disease	0.000418	0.00113	CcSEcCtD
Sitaxentan—Conjunctivitis—Donepezil—Alzheimer's disease	0.000417	0.00113	CcSEcCtD
Sitaxentan—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000416	0.00112	CcSEcCtD
Sitaxentan—Muscle spasms—Galantamine—Alzheimer's disease	0.000416	0.00112	CcSEcCtD
Sitaxentan—Pancytopenia—Memantine—Alzheimer's disease	0.000415	0.00112	CcSEcCtD
Sitaxentan—Bronchitis—Rivastigmine—Alzheimer's disease	0.000411	0.00111	CcSEcCtD
Sitaxentan—Haematuria—Donepezil—Alzheimer's disease	0.000409	0.0011	CcSEcCtD
Sitaxentan—Dysuria—Memantine—Alzheimer's disease	0.000409	0.0011	CcSEcCtD
Sitaxentan—Tremor—Galantamine—Alzheimer's disease	0.000405	0.00109	CcSEcCtD
Sitaxentan—Epistaxis—Donepezil—Alzheimer's disease	0.000405	0.00109	CcSEcCtD
Sitaxentan—Pollakiuria—Memantine—Alzheimer's disease	0.000404	0.00109	CcSEcCtD
Sitaxentan—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000401	0.00108	CcSEcCtD
Sitaxentan—Anaemia—Galantamine—Alzheimer's disease	0.0004	0.00108	CcSEcCtD
Sitaxentan—Dysuria—Rivastigmine—Alzheimer's disease	0.0004	0.00108	CcSEcCtD
Sitaxentan—Agitation—Galantamine—Alzheimer's disease	0.000398	0.00107	CcSEcCtD
Sitaxentan—Weight decreased—Memantine—Alzheimer's disease	0.000395	0.00107	CcSEcCtD
Sitaxentan—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000395	0.00107	CcSEcCtD
Sitaxentan—Hyperglycaemia—Memantine—Alzheimer's disease	0.000394	0.00106	CcSEcCtD
Sitaxentan—Bradycardia—Donepezil—Alzheimer's disease	0.000392	0.00106	CcSEcCtD
Sitaxentan—Malaise—Galantamine—Alzheimer's disease	0.00039	0.00105	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00039	0.00105	CcSEcCtD
Sitaxentan—Infestation NOS—Memantine—Alzheimer's disease	0.00039	0.00105	CcSEcCtD
Sitaxentan—Infestation—Memantine—Alzheimer's disease	0.00039	0.00105	CcSEcCtD
Sitaxentan—Vertigo—Galantamine—Alzheimer's disease	0.000389	0.00105	CcSEcCtD
Sitaxentan—Haemoglobin—Donepezil—Alzheimer's disease	0.000387	0.00104	CcSEcCtD
Sitaxentan—Weight decreased—Rivastigmine—Alzheimer's disease	0.000387	0.00104	CcSEcCtD
Sitaxentan—Rhinitis—Donepezil—Alzheimer's disease	0.000386	0.00104	CcSEcCtD
Sitaxentan—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000386	0.00104	CcSEcCtD
Sitaxentan—Haemorrhage—Donepezil—Alzheimer's disease	0.000385	0.00104	CcSEcCtD
Sitaxentan—Hepatitis—Donepezil—Alzheimer's disease	0.000385	0.00104	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000384	0.00104	CcSEcCtD
Sitaxentan—Renal failure—Memantine—Alzheimer's disease	0.000383	0.00103	CcSEcCtD
Sitaxentan—Myocardial infarction—Memantine—Alzheimer's disease	0.000382	0.00103	CcSEcCtD
Sitaxentan—Infestation—Rivastigmine—Alzheimer's disease	0.000381	0.00103	CcSEcCtD
Sitaxentan—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000381	0.00103	CcSEcCtD
Sitaxentan—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00038	0.00103	CcSEcCtD
Sitaxentan—Oedema peripheral—Donepezil—Alzheimer's disease	0.000379	0.00102	CcSEcCtD
Sitaxentan—Conjunctivitis—Memantine—Alzheimer's disease	0.000379	0.00102	CcSEcCtD
Sitaxentan—Urethral disorder—Donepezil—Alzheimer's disease	0.000378	0.00102	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000376	0.00101	CcSEcCtD
Sitaxentan—Renal failure—Rivastigmine—Alzheimer's disease	0.000375	0.00101	CcSEcCtD
Sitaxentan—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000374	0.00101	CcSEcCtD
Sitaxentan—Haematuria—Memantine—Alzheimer's disease	0.000371	0.001	CcSEcCtD
Sitaxentan—Visual impairment—Donepezil—Alzheimer's disease	0.000371	0.001	CcSEcCtD
Sitaxentan—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00037	0.001	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000368	0.000994	CcSEcCtD
Sitaxentan—Chest pain—Galantamine—Alzheimer's disease	0.000368	0.000994	CcSEcCtD
Sitaxentan—Epistaxis—Memantine—Alzheimer's disease	0.000367	0.000992	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000366	0.000987	CcSEcCtD
Sitaxentan—Sinusitis—Memantine—Alzheimer's disease	0.000365	0.000986	CcSEcCtD
Sitaxentan—Discomfort—Galantamine—Alzheimer's disease	0.000364	0.000982	CcSEcCtD
Sitaxentan—Haematuria—Rivastigmine—Alzheimer's disease	0.000363	0.000981	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00036	0.000973	CcSEcCtD
Sitaxentan—Dry mouth—Galantamine—Alzheimer's disease	0.00036	0.000972	CcSEcCtD
Sitaxentan—Epistaxis—Rivastigmine—Alzheimer's disease	0.000359	0.00097	CcSEcCtD
Sitaxentan—Tinnitus—Donepezil—Alzheimer's disease	0.000359	0.000969	CcSEcCtD
Sitaxentan—Sinusitis—Rivastigmine—Alzheimer's disease	0.000358	0.000965	CcSEcCtD
Sitaxentan—Confusional state—Galantamine—Alzheimer's disease	0.000356	0.000961	CcSEcCtD
Sitaxentan—Bradycardia—Memantine—Alzheimer's disease	0.000356	0.000961	CcSEcCtD
Sitaxentan—Haemoglobin—Memantine—Alzheimer's disease	0.000351	0.000949	CcSEcCtD
Sitaxentan—Rhinitis—Memantine—Alzheimer's disease	0.000351	0.000946	CcSEcCtD
Sitaxentan—Haemorrhage—Memantine—Alzheimer's disease	0.00035	0.000944	CcSEcCtD
Sitaxentan—Hepatitis—Memantine—Alzheimer's disease	0.00035	0.000944	CcSEcCtD
Sitaxentan—Bradycardia—Rivastigmine—Alzheimer's disease	0.000348	0.00094	CcSEcCtD
Sitaxentan—Nervous system disorder—Galantamine—Alzheimer's disease	0.000346	0.000935	CcSEcCtD
Sitaxentan—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000346	0.000933	CcSEcCtD
Sitaxentan—Urinary tract disorder—Memantine—Alzheimer's disease	0.000345	0.000932	CcSEcCtD
Sitaxentan—Tachycardia—Galantamine—Alzheimer's disease	0.000345	0.00093	CcSEcCtD
Sitaxentan—Oedema peripheral—Memantine—Alzheimer's disease	0.000344	0.00093	CcSEcCtD
Sitaxentan—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000344	0.000928	CcSEcCtD
Sitaxentan—Rhinitis—Rivastigmine—Alzheimer's disease	0.000343	0.000926	CcSEcCtD
Sitaxentan—Skin disorder—Galantamine—Alzheimer's disease	0.000343	0.000926	CcSEcCtD
Sitaxentan—Urethral disorder—Memantine—Alzheimer's disease	0.000343	0.000925	CcSEcCtD
Sitaxentan—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000342	0.000923	CcSEcCtD
Sitaxentan—Hepatitis—Rivastigmine—Alzheimer's disease	0.000342	0.000923	CcSEcCtD
Sitaxentan—Alopecia—Donepezil—Alzheimer's disease	0.00034	0.000919	CcSEcCtD
Sitaxentan—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000338	0.000912	CcSEcCtD
Sitaxentan—Mental disorder—Donepezil—Alzheimer's disease	0.000337	0.000911	CcSEcCtD
Sitaxentan—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000337	0.00091	CcSEcCtD
Sitaxentan—Visual impairment—Memantine—Alzheimer's disease	0.000337	0.00091	CcSEcCtD
Sitaxentan—Anorexia—Galantamine—Alzheimer's disease	0.000337	0.000908	CcSEcCtD
Sitaxentan—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000335	0.000905	CcSEcCtD
Sitaxentan—Malnutrition—Donepezil—Alzheimer's disease	0.000335	0.000905	CcSEcCtD
Sitaxentan—Hypotension—Galantamine—Alzheimer's disease	0.00033	0.000891	CcSEcCtD
Sitaxentan—Visual impairment—Rivastigmine—Alzheimer's disease	0.00033	0.00089	CcSEcCtD
Sitaxentan—Tension—Donepezil—Alzheimer's disease	0.000329	0.000888	CcSEcCtD
Sitaxentan—Eye disorder—Memantine—Alzheimer's disease	0.000327	0.000882	CcSEcCtD
Sitaxentan—Tinnitus—Memantine—Alzheimer's disease	0.000326	0.00088	CcSEcCtD
Sitaxentan—Nervousness—Donepezil—Alzheimer's disease	0.000326	0.000879	CcSEcCtD
Sitaxentan—Cardiac disorder—Memantine—Alzheimer's disease	0.000325	0.000876	CcSEcCtD
Sitaxentan—Flushing—Memantine—Alzheimer's disease	0.000325	0.000876	CcSEcCtD
Sitaxentan—Muscle spasms—Donepezil—Alzheimer's disease	0.000322	0.00087	CcSEcCtD
Sitaxentan—Eye disorder—Rivastigmine—Alzheimer's disease	0.00032	0.000863	CcSEcCtD
Sitaxentan—Insomnia—Galantamine—Alzheimer's disease	0.000319	0.000862	CcSEcCtD
Sitaxentan—Tinnitus—Rivastigmine—Alzheimer's disease	0.000319	0.000861	CcSEcCtD
Sitaxentan—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000317	0.000857	CcSEcCtD
Sitaxentan—Flushing—Rivastigmine—Alzheimer's disease	0.000317	0.000857	CcSEcCtD
Sitaxentan—Angiopathy—Memantine—Alzheimer's disease	0.000317	0.000856	CcSEcCtD
Sitaxentan—Immune system disorder—Memantine—Alzheimer's disease	0.000316	0.000853	CcSEcCtD
Sitaxentan—Mediastinal disorder—Memantine—Alzheimer's disease	0.000315	0.000851	CcSEcCtD
Sitaxentan—Tremor—Donepezil—Alzheimer's disease	0.000314	0.000848	CcSEcCtD
Sitaxentan—Somnolence—Galantamine—Alzheimer's disease	0.000314	0.000847	CcSEcCtD
Sitaxentan—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000311	0.00084	CcSEcCtD
Sitaxentan—Dyspepsia—Galantamine—Alzheimer's disease	0.000311	0.000839	CcSEcCtD
Sitaxentan—Angiopathy—Rivastigmine—Alzheimer's disease	0.00031	0.000838	CcSEcCtD
Sitaxentan—Anaemia—Donepezil—Alzheimer's disease	0.00031	0.000836	CcSEcCtD
Sitaxentan—Alopecia—Memantine—Alzheimer's disease	0.000309	0.000834	CcSEcCtD
Sitaxentan—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000308	0.000832	CcSEcCtD
Sitaxentan—Agitation—Donepezil—Alzheimer's disease	0.000308	0.000832	CcSEcCtD
Sitaxentan—Decreased appetite—Galantamine—Alzheimer's disease	0.000307	0.000828	CcSEcCtD
Sitaxentan—Mental disorder—Memantine—Alzheimer's disease	0.000306	0.000827	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000305	0.000823	CcSEcCtD
Sitaxentan—Malnutrition—Memantine—Alzheimer's disease	0.000304	0.000822	CcSEcCtD
Sitaxentan—Fatigue—Galantamine—Alzheimer's disease	0.000304	0.000822	CcSEcCtD
Sitaxentan—Malaise—Donepezil—Alzheimer's disease	0.000302	0.000816	CcSEcCtD
Sitaxentan—Alopecia—Rivastigmine—Alzheimer's disease	0.000302	0.000816	CcSEcCtD
Sitaxentan—Constipation—Galantamine—Alzheimer's disease	0.000302	0.000815	CcSEcCtD
Sitaxentan—Vertigo—Donepezil—Alzheimer's disease	0.000301	0.000813	CcSEcCtD
Sitaxentan—Mental disorder—Rivastigmine—Alzheimer's disease	0.0003	0.000809	CcSEcCtD
Sitaxentan—Tension—Memantine—Alzheimer's disease	0.000299	0.000806	CcSEcCtD
Sitaxentan—Malnutrition—Rivastigmine—Alzheimer's disease	0.000298	0.000804	CcSEcCtD
Sitaxentan—Nervousness—Memantine—Alzheimer's disease	0.000296	0.000798	CcSEcCtD
Sitaxentan—Tension—Rivastigmine—Alzheimer's disease	0.000292	0.000789	CcSEcCtD
Sitaxentan—Feeling abnormal—Galantamine—Alzheimer's disease	0.000291	0.000785	CcSEcCtD
Sitaxentan—Nervousness—Rivastigmine—Alzheimer's disease	0.000289	0.000781	CcSEcCtD
Sitaxentan—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000286	0.000773	CcSEcCtD
Sitaxentan—Chest pain—Donepezil—Alzheimer's disease	0.000285	0.00077	CcSEcCtD
Sitaxentan—Tremor—Memantine—Alzheimer's disease	0.000285	0.00077	CcSEcCtD
Sitaxentan—Ill-defined disorder—Memantine—Alzheimer's disease	0.000282	0.000762	CcSEcCtD
Sitaxentan—Discomfort—Donepezil—Alzheimer's disease	0.000282	0.000761	CcSEcCtD
Sitaxentan—Anaemia—Memantine—Alzheimer's disease	0.000281	0.000759	CcSEcCtD
Sitaxentan—Agitation—Memantine—Alzheimer's disease	0.00028	0.000755	CcSEcCtD
Sitaxentan—Dry mouth—Donepezil—Alzheimer's disease	0.000279	0.000753	CcSEcCtD
Sitaxentan—Body temperature increased—Galantamine—Alzheimer's disease	0.000279	0.000753	CcSEcCtD
Sitaxentan—Tremor—Rivastigmine—Alzheimer's disease	0.000279	0.000753	CcSEcCtD
Sitaxentan—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000276	0.000746	CcSEcCtD
Sitaxentan—Confusional state—Donepezil—Alzheimer's disease	0.000276	0.000745	CcSEcCtD
Sitaxentan—Anaemia—Rivastigmine—Alzheimer's disease	0.000275	0.000743	CcSEcCtD
Sitaxentan—Malaise—Memantine—Alzheimer's disease	0.000275	0.000741	CcSEcCtD
Sitaxentan—Agitation—Rivastigmine—Alzheimer's disease	0.000274	0.000739	CcSEcCtD
Sitaxentan—Oedema—Donepezil—Alzheimer's disease	0.000274	0.000739	CcSEcCtD
Sitaxentan—Vertigo—Memantine—Alzheimer's disease	0.000273	0.000738	CcSEcCtD
Sitaxentan—Leukopenia—Memantine—Alzheimer's disease	0.000272	0.000736	CcSEcCtD
Sitaxentan—Infection—Donepezil—Alzheimer's disease	0.000272	0.000734	CcSEcCtD
Sitaxentan—Malaise—Rivastigmine—Alzheimer's disease	0.000269	0.000725	CcSEcCtD
Sitaxentan—Nervous system disorder—Donepezil—Alzheimer's disease	0.000268	0.000724	CcSEcCtD
Sitaxentan—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000268	0.000723	CcSEcCtD
Sitaxentan—Vertigo—Rivastigmine—Alzheimer's disease	0.000268	0.000722	CcSEcCtD
Sitaxentan—Anorexia—Donepezil—Alzheimer's disease	0.000261	0.000704	CcSEcCtD
Sitaxentan—Hypersensitivity—Galantamine—Alzheimer's disease	0.00026	0.000702	CcSEcCtD
Sitaxentan—Chest pain—Memantine—Alzheimer's disease	0.000259	0.0007	CcSEcCtD
Sitaxentan—Discomfort—Memantine—Alzheimer's disease	0.000256	0.000691	CcSEcCtD
Sitaxentan—Hypotension—Donepezil—Alzheimer's disease	0.000256	0.00069	CcSEcCtD
Sitaxentan—Chest pain—Rivastigmine—Alzheimer's disease	0.000254	0.000684	CcSEcCtD
Sitaxentan—Dry mouth—Memantine—Alzheimer's disease	0.000253	0.000684	CcSEcCtD
Sitaxentan—Asthenia—Galantamine—Alzheimer's disease	0.000253	0.000684	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000252	0.00068	CcSEcCtD
Sitaxentan—Confusional state—Memantine—Alzheimer's disease	0.000251	0.000676	CcSEcCtD
Sitaxentan—Discomfort—Rivastigmine—Alzheimer's disease	0.00025	0.000676	CcSEcCtD
Sitaxentan—Oedema—Memantine—Alzheimer's disease	0.000248	0.000671	CcSEcCtD
Sitaxentan—Dry mouth—Rivastigmine—Alzheimer's disease	0.000248	0.000669	CcSEcCtD
Sitaxentan—Insomnia—Donepezil—Alzheimer's disease	0.000247	0.000668	CcSEcCtD
Sitaxentan—Infection—Memantine—Alzheimer's disease	0.000247	0.000666	CcSEcCtD
Sitaxentan—Confusional state—Rivastigmine—Alzheimer's disease	0.000245	0.000661	CcSEcCtD
Sitaxentan—Nervous system disorder—Memantine—Alzheimer's disease	0.000244	0.000658	CcSEcCtD
Sitaxentan—Somnolence—Donepezil—Alzheimer's disease	0.000243	0.000657	CcSEcCtD
Sitaxentan—Thrombocytopenia—Memantine—Alzheimer's disease	0.000243	0.000657	CcSEcCtD
Sitaxentan—Oedema—Rivastigmine—Alzheimer's disease	0.000243	0.000656	CcSEcCtD
Sitaxentan—Tachycardia—Memantine—Alzheimer's disease	0.000242	0.000654	CcSEcCtD
Sitaxentan—Diarrhoea—Galantamine—Alzheimer's disease	0.000242	0.000652	CcSEcCtD
Sitaxentan—Infection—Rivastigmine—Alzheimer's disease	0.000241	0.000652	CcSEcCtD
Sitaxentan—Skin disorder—Memantine—Alzheimer's disease	0.000241	0.000651	CcSEcCtD
Sitaxentan—Dyspepsia—Donepezil—Alzheimer's disease	0.000241	0.00065	CcSEcCtD
Sitaxentan—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000238	0.000643	CcSEcCtD
Sitaxentan—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000238	0.000642	CcSEcCtD
Sitaxentan—Decreased appetite—Donepezil—Alzheimer's disease	0.000238	0.000642	CcSEcCtD
Sitaxentan—Tachycardia—Rivastigmine—Alzheimer's disease	0.000237	0.00064	CcSEcCtD
Sitaxentan—Anorexia—Memantine—Alzheimer's disease	0.000237	0.000639	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000236	0.000638	CcSEcCtD
Sitaxentan—Skin disorder—Rivastigmine—Alzheimer's disease	0.000236	0.000637	CcSEcCtD
Sitaxentan—Fatigue—Donepezil—Alzheimer's disease	0.000236	0.000637	CcSEcCtD
Sitaxentan—Constipation—Donepezil—Alzheimer's disease	0.000234	0.000632	CcSEcCtD
Sitaxentan—Pain—Donepezil—Alzheimer's disease	0.000234	0.000632	CcSEcCtD
Sitaxentan—Dizziness—Galantamine—Alzheimer's disease	0.000233	0.00063	CcSEcCtD
Sitaxentan—Hypotension—Memantine—Alzheimer's disease	0.000232	0.000627	CcSEcCtD
Sitaxentan—Anorexia—Rivastigmine—Alzheimer's disease	0.000232	0.000625	CcSEcCtD
Sitaxentan—Hypotension—Rivastigmine—Alzheimer's disease	0.000227	0.000613	CcSEcCtD
Sitaxentan—Feeling abnormal—Donepezil—Alzheimer's disease	0.000225	0.000609	CcSEcCtD
Sitaxentan—Insomnia—Memantine—Alzheimer's disease	0.000225	0.000607	CcSEcCtD
Sitaxentan—Vomiting—Galantamine—Alzheimer's disease	0.000224	0.000606	CcSEcCtD
Sitaxentan—Rash—Galantamine—Alzheimer's disease	0.000223	0.000601	CcSEcCtD
Sitaxentan—Dermatitis—Galantamine—Alzheimer's disease	0.000222	0.0006	CcSEcCtD
Sitaxentan—Headache—Galantamine—Alzheimer's disease	0.000221	0.000597	CcSEcCtD
Sitaxentan—Somnolence—Memantine—Alzheimer's disease	0.000221	0.000596	CcSEcCtD
Sitaxentan—Insomnia—Rivastigmine—Alzheimer's disease	0.00022	0.000593	CcSEcCtD
Sitaxentan—Dyspepsia—Memantine—Alzheimer's disease	0.000219	0.00059	CcSEcCtD
Sitaxentan—Urticaria—Donepezil—Alzheimer's disease	0.000217	0.000587	CcSEcCtD
Sitaxentan—Body temperature increased—Donepezil—Alzheimer's disease	0.000216	0.000584	CcSEcCtD
Sitaxentan—Somnolence—Rivastigmine—Alzheimer's disease	0.000216	0.000583	CcSEcCtD
Sitaxentan—Decreased appetite—Memantine—Alzheimer's disease	0.000216	0.000583	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000214	0.000579	CcSEcCtD
Sitaxentan—Fatigue—Memantine—Alzheimer's disease	0.000214	0.000578	CcSEcCtD
Sitaxentan—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000214	0.000577	CcSEcCtD
Sitaxentan—Constipation—Memantine—Alzheimer's disease	0.000212	0.000573	CcSEcCtD
Sitaxentan—Pain—Memantine—Alzheimer's disease	0.000212	0.000573	CcSEcCtD
Sitaxentan—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000211	0.00057	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00021	0.000566	CcSEcCtD
Sitaxentan—Nausea—Galantamine—Alzheimer's disease	0.00021	0.000566	CcSEcCtD
Sitaxentan—Fatigue—Rivastigmine—Alzheimer's disease	0.00021	0.000566	CcSEcCtD
Sitaxentan—Pain—Rivastigmine—Alzheimer's disease	0.000208	0.000561	CcSEcCtD
Sitaxentan—Constipation—Rivastigmine—Alzheimer's disease	0.000208	0.000561	CcSEcCtD
Sitaxentan—Feeling abnormal—Memantine—Alzheimer's disease	0.000205	0.000553	CcSEcCtD
Sitaxentan—Hypersensitivity—Donepezil—Alzheimer's disease	0.000202	0.000544	CcSEcCtD
Sitaxentan—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.0002	0.000541	CcSEcCtD
Sitaxentan—Urticaria—Memantine—Alzheimer's disease	0.000197	0.000533	CcSEcCtD
Sitaxentan—Body temperature increased—Memantine—Alzheimer's disease	0.000196	0.00053	CcSEcCtD
Sitaxentan—Asthenia—Donepezil—Alzheimer's disease	0.000196	0.00053	CcSEcCtD
Sitaxentan—Urticaria—Rivastigmine—Alzheimer's disease	0.000193	0.000521	CcSEcCtD
Sitaxentan—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000192	0.000519	CcSEcCtD
Sitaxentan—Diarrhoea—Donepezil—Alzheimer's disease	0.000187	0.000505	CcSEcCtD
Sitaxentan—Hypersensitivity—Memantine—Alzheimer's disease	0.000183	0.000494	CcSEcCtD
Sitaxentan—Dizziness—Donepezil—Alzheimer's disease	0.000181	0.000488	CcSEcCtD
Sitaxentan—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000179	0.000483	CcSEcCtD
Sitaxentan—Asthenia—Memantine—Alzheimer's disease	0.000178	0.000481	CcSEcCtD
Sitaxentan—Asthenia—Rivastigmine—Alzheimer's disease	0.000174	0.000471	CcSEcCtD
Sitaxentan—Vomiting—Donepezil—Alzheimer's disease	0.000174	0.00047	CcSEcCtD
Sitaxentan—Rash—Donepezil—Alzheimer's disease	0.000173	0.000466	CcSEcCtD
Sitaxentan—Dermatitis—Donepezil—Alzheimer's disease	0.000172	0.000465	CcSEcCtD
Sitaxentan—Headache—Donepezil—Alzheimer's disease	0.000171	0.000463	CcSEcCtD
Sitaxentan—Diarrhoea—Memantine—Alzheimer's disease	0.00017	0.000459	CcSEcCtD
Sitaxentan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000166	0.000449	CcSEcCtD
Sitaxentan—Dizziness—Memantine—Alzheimer's disease	0.000164	0.000443	CcSEcCtD
Sitaxentan—Nausea—Donepezil—Alzheimer's disease	0.000163	0.000439	CcSEcCtD
Sitaxentan—Dizziness—Rivastigmine—Alzheimer's disease	0.000161	0.000434	CcSEcCtD
Sitaxentan—Vomiting—Memantine—Alzheimer's disease	0.000158	0.000426	CcSEcCtD
Sitaxentan—Rash—Memantine—Alzheimer's disease	0.000157	0.000423	CcSEcCtD
Sitaxentan—Dermatitis—Memantine—Alzheimer's disease	0.000157	0.000422	CcSEcCtD
Sitaxentan—Headache—Memantine—Alzheimer's disease	0.000156	0.00042	CcSEcCtD
Sitaxentan—Vomiting—Rivastigmine—Alzheimer's disease	0.000155	0.000417	CcSEcCtD
Sitaxentan—Rash—Rivastigmine—Alzheimer's disease	0.000153	0.000414	CcSEcCtD
Sitaxentan—Dermatitis—Rivastigmine—Alzheimer's disease	0.000153	0.000413	CcSEcCtD
Sitaxentan—Headache—Rivastigmine—Alzheimer's disease	0.000152	0.000411	CcSEcCtD
Sitaxentan—Nausea—Memantine—Alzheimer's disease	0.000148	0.000398	CcSEcCtD
Sitaxentan—Nausea—Rivastigmine—Alzheimer's disease	0.000144	0.00039	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—PLCB1—Alzheimer's disease	9.61e-05	0.000908	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	9.55e-05	0.000903	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CRH—Alzheimer's disease	9.54e-05	0.000902	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NCSTN—Alzheimer's disease	9.45e-05	0.000894	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	9.41e-05	0.00089	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CCR5—Alzheimer's disease	9.41e-05	0.000889	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—LRP1—Alzheimer's disease	9.22e-05	0.000872	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HTR2A—Alzheimer's disease	9.21e-05	0.00087	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	9.06e-05	0.000857	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NPS—Alzheimer's disease	9.04e-05	0.000855	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GFAP—Alzheimer's disease	9e-05	0.000851	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GAL—Alzheimer's disease	9e-05	0.000851	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PPP3CA—Alzheimer's disease	8.99e-05	0.00085	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	8.96e-05	0.000847	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—F2—Alzheimer's disease	8.89e-05	0.00084	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PTK2B—Alzheimer's disease	8.86e-05	0.000838	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SST—Alzheimer's disease	8.62e-05	0.000815	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GAB2—Alzheimer's disease	8.62e-05	0.000815	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NTRK2—Alzheimer's disease	8.62e-05	0.000815	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CALM1—Alzheimer's disease	8.59e-05	0.000812	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GSK3A—Alzheimer's disease	8.55e-05	0.000808	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	8.47e-05	0.000801	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—APP—Alzheimer's disease	8.4e-05	0.000795	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	8.27e-05	0.000782	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—F2—Alzheimer's disease	8.07e-05	0.000763	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—A2M—Alzheimer's disease	7.94e-05	0.00075	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PLCB1—Alzheimer's disease	7.93e-05	0.00075	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	7.9e-05	0.000747	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—PRKCG—Alzheimer's disease	7.82e-05	0.00074	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PSEN2—Alzheimer's disease	7.69e-05	0.000727	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CCR5—Alzheimer's disease	7.41e-05	0.000701	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NGFR—Alzheimer's disease	7.4e-05	0.0007	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CREB1—Alzheimer's disease	7.35e-05	0.000695	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—HTR2A—Alzheimer's disease	7.25e-05	0.000686	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ADAM10—Alzheimer's disease	7.23e-05	0.000683	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CCL2—Alzheimer's disease	7.19e-05	0.00068	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PRKCG—Alzheimer's disease	7.1e-05	0.000672	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NPY—Alzheimer's disease	7.07e-05	0.000669	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IAPP—Alzheimer's disease	7.03e-05	0.000665	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—S100B—Alzheimer's disease	6.83e-05	0.000646	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CRH—Alzheimer's disease	6.82e-05	0.000645	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CCR5—Alzheimer's disease	6.73e-05	0.000637	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HTR2A—Alzheimer's disease	6.59e-05	0.000623	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IGF2—Alzheimer's disease	6.51e-05	0.000615	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NPS—Alzheimer's disease	6.47e-05	0.000612	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PPP3CA—Alzheimer's disease	6.44e-05	0.000609	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	6.42e-05	0.000607	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—F2—Alzheimer's disease	6.36e-05	0.000601	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PTK2B—Alzheimer's disease	6.34e-05	0.0006	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	6.29e-05	0.000595	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IGF1R—Alzheimer's disease	6.29e-05	0.000595	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	6.21e-05	0.000587	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NTRK2—Alzheimer's disease	6.17e-05	0.000584	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SST—Alzheimer's disease	6.17e-05	0.000584	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GAB2—Alzheimer's disease	6.17e-05	0.000584	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CALM1—Alzheimer's disease	6.15e-05	0.000581	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GSK3A—Alzheimer's disease	6.12e-05	0.000578	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—DHCR24—Alzheimer's disease	6.05e-05	0.000572	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—LPL—Alzheimer's disease	6.03e-05	0.00057	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—APP—Alzheimer's disease	6.01e-05	0.000569	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MEF2C—Alzheimer's disease	5.98e-05	0.000565	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PRKCG—Alzheimer's disease	5.86e-05	0.000555	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—F2—Alzheimer's disease	5.78e-05	0.000546	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NGF—Alzheimer's disease	5.71e-05	0.00054	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PLCB1—Alzheimer's disease	5.67e-05	0.000537	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	5.64e-05	0.000533	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCR5—Alzheimer's disease	5.56e-05	0.000525	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	5.52e-05	0.000522	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HTR2A—Alzheimer's disease	5.44e-05	0.000514	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NGFR—Alzheimer's disease	5.29e-05	0.000501	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CREB1—Alzheimer's disease	5.26e-05	0.000498	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ADAM10—Alzheimer's disease	5.17e-05	0.000489	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CCL2—Alzheimer's disease	5.15e-05	0.000487	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CA4—Alzheimer's disease	5.14e-05	0.000486	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	5.14e-05	0.000486	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CALM1—Alzheimer's disease	5.07e-05	0.00048	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—APOE—Alzheimer's disease	5.06e-05	0.000478	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—LEP—Alzheimer's disease	5.06e-05	0.000478	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	5.03e-05	0.000475	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CAV1—Alzheimer's disease	5.01e-05	0.000474	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—S100B—Alzheimer's disease	4.89e-05	0.000462	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	4.84e-05	0.000457	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ESR1—Alzheimer's disease	4.83e-05	0.000456	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—F2—Alzheimer's disease	4.77e-05	0.000451	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CA4—Alzheimer's disease	4.69e-05	0.000444	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NOTCH1—Alzheimer's disease	4.67e-05	0.000441	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IGF2—Alzheimer's disease	4.66e-05	0.00044	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	4.59e-05	0.000434	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.58e-05	0.000434	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IGF1R—Alzheimer's disease	4.5e-05	0.000426	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	4.41e-05	0.000417	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GSK3B—Alzheimer's disease	4.38e-05	0.000414	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PLD3—Alzheimer's disease	4.37e-05	0.000414	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.37e-05	0.000414	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CREB1—Alzheimer's disease	4.34e-05	0.000411	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.32e-05	0.000409	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—INS—Alzheimer's disease	4.32e-05	0.000408	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—LPL—Alzheimer's disease	4.32e-05	0.000408	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MEF2C—Alzheimer's disease	4.28e-05	0.000405	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCL2—Alzheimer's disease	4.25e-05	0.000402	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PRKCG—Alzheimer's disease	4.2e-05	0.000397	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	4.19e-05	0.000397	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	4.18e-05	0.000395	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IGF1—Alzheimer's disease	4.18e-05	0.000395	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	4.1e-05	0.000388	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NGF—Alzheimer's disease	4.09e-05	0.000387	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	4.04e-05	0.000382	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PLD3—Alzheimer's disease	3.99e-05	0.000377	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.99e-05	0.000377	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCR5—Alzheimer's disease	3.98e-05	0.000376	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.94e-05	0.000373	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ND1—Alzheimer's disease	3.9e-05	0.000369	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HTR2A—Alzheimer's disease	3.89e-05	0.000368	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	3.82e-05	0.000362	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.81e-05	0.00036	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NOS3—Alzheimer's disease	3.79e-05	0.000358	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.74e-05	0.000353	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	3.68e-05	0.000348	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	3.64e-05	0.000344	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CALM1—Alzheimer's disease	3.63e-05	0.000343	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—LEP—Alzheimer's disease	3.62e-05	0.000342	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—APOE—Alzheimer's disease	3.62e-05	0.000342	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CAV1—Alzheimer's disease	3.58e-05	0.000339	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ND1—Alzheimer's disease	3.56e-05	0.000336	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.49e-05	0.00033	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.47e-05	0.000329	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ESR1—Alzheimer's disease	3.45e-05	0.000327	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—F2—Alzheimer's disease	3.41e-05	0.000323	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOTCH1—Alzheimer's disease	3.34e-05	0.000316	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—AKT1—Alzheimer's disease	3.25e-05	0.000307	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CASP3—Alzheimer's disease	3.22e-05	0.000304	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL6—Alzheimer's disease	3.19e-05	0.000302	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.18e-05	0.000301	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GSK3B—Alzheimer's disease	3.13e-05	0.000296	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CREB1—Alzheimer's disease	3.11e-05	0.000294	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CA4—Alzheimer's disease	3.09e-05	0.000293	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—INS—Alzheimer's disease	3.09e-05	0.000292	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL2—Alzheimer's disease	3.04e-05	0.000288	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3e-05	0.000284	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IGF1—Alzheimer's disease	2.99e-05	0.000283	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MAPK8—Alzheimer's disease	2.96e-05	0.000279	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—AKT1—Alzheimer's disease	2.95e-05	0.000279	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.91e-05	0.000275	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.76e-05	0.000261	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.74e-05	0.000259	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.73e-05	0.000259	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VEGFA—Alzheimer's disease	2.73e-05	0.000258	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOS3—Alzheimer's disease	2.71e-05	0.000256	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.63e-05	0.000249	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.52e-05	0.000238	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CHAT—Alzheimer's disease	2.51e-05	0.000238	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—TPI1—Alzheimer's disease	2.51e-05	0.000238	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TGFB1—Alzheimer's disease	2.5e-05	0.000237	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.49e-05	0.000236	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.43e-05	0.00023	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MAOB—Alzheimer's disease	2.41e-05	0.000228	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.34e-05	0.000222	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—AKT1—Alzheimer's disease	2.32e-05	0.00022	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	2.32e-05	0.000219	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CASP3—Alzheimer's disease	2.3e-05	0.000218	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.29e-05	0.000217	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—TPI1—Alzheimer's disease	2.29e-05	0.000217	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CHAT—Alzheimer's disease	2.29e-05	0.000217	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6—Alzheimer's disease	2.29e-05	0.000216	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.27e-05	0.000215	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—A2M—Alzheimer's disease	2.24e-05	0.000212	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MAOB—Alzheimer's disease	2.2e-05	0.000208	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MAPK8—Alzheimer's disease	2.12e-05	0.0002	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	2.11e-05	0.0002	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—AKT1—Alzheimer's disease	2.11e-05	0.000199	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.09e-05	0.000198	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.07e-05	0.000196	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TP53—Alzheimer's disease	2.06e-05	0.000195	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—A2M—Alzheimer's disease	2.04e-05	0.000193	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2e-05	0.000189	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VEGFA—Alzheimer's disease	1.95e-05	0.000185	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ACHE—Alzheimer's disease	1.95e-05	0.000184	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	1.93e-05	0.000182	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6—Alzheimer's disease	1.89e-05	0.000178	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	1.83e-05	0.000173	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ENO1—Alzheimer's disease	1.83e-05	0.000173	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.82e-05	0.000172	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TGFB1—Alzheimer's disease	1.79e-05	0.000169	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	1.79e-05	0.000169	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ACHE—Alzheimer's disease	1.78e-05	0.000168	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	1.76e-05	0.000166	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—AKT1—Alzheimer's disease	1.74e-05	0.000165	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—BCHE—Alzheimer's disease	1.7e-05	0.00016	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ENO1—Alzheimer's disease	1.66e-05	0.000157	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	1.66e-05	0.000157	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	1.63e-05	0.000154	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	1.6e-05	0.000151	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.57e-05	0.000149	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	1.55e-05	0.000147	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—BCHE—Alzheimer's disease	1.55e-05	0.000146	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.51e-05	0.000143	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.51e-05	0.000143	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TP53—Alzheimer's disease	1.48e-05	0.00014	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	1.46e-05	0.000138	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.45e-05	0.000137	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.43e-05	0.000135	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	1.42e-05	0.000134	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.39e-05	0.000132	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6—Alzheimer's disease	1.35e-05	0.000128	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.35e-05	0.000127	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	1.34e-05	0.000127	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	1.33e-05	0.000126	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AKT1—Alzheimer's disease	1.25e-05	0.000118	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	1.22e-05	0.000115	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LPL—Alzheimer's disease	1.22e-05	0.000115	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	1.21e-05	0.000115	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.17e-05	0.000111	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.16e-05	0.000109	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LPL—Alzheimer's disease	1.11e-05	0.000105	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.1e-05	0.000104	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.1e-05	0.000104	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	1.1e-05	0.000104	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.08e-05	0.000102	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CALM1—Alzheimer's disease	1.02e-05	9.69e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOE—Alzheimer's disease	1.02e-05	9.65e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.02e-05	9.65e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CAV1—Alzheimer's disease	1.01e-05	9.57e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1e-05	9.46e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	9.63e-06	9.11e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CALM1—Alzheimer's disease	9.34e-06	8.83e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	9.33e-06	8.83e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOE—Alzheimer's disease	9.31e-06	8.8e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CAV1—Alzheimer's disease	9.22e-06	8.72e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARG—Alzheimer's disease	8.89e-06	8.41e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—INS—Alzheimer's disease	8.72e-06	8.25e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARG—Alzheimer's disease	8.11e-06	7.67e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	8.04e-06	7.61e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	8.01e-06	7.57e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—INS—Alzheimer's disease	7.95e-06	7.52e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NOS3—Alzheimer's disease	7.65e-06	7.23e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LPL—Alzheimer's disease	7.32e-06	6.93e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	7e-06	6.62e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NOS3—Alzheimer's disease	6.97e-06	6.59e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	6.59e-06	6.24e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	6.38e-06	6.03e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CALM1—Alzheimer's disease	6.16e-06	5.83e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOE—Alzheimer's disease	6.14e-06	5.81e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CAV1—Alzheimer's disease	6.08e-06	5.75e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARG—Alzheimer's disease	5.35e-06	5.06e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—INS—Alzheimer's disease	5.24e-06	4.96e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NOS3—Alzheimer's disease	4.6e-06	4.35e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	4.21e-06	3.98e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AKT1—Alzheimer's disease	3.52e-06	3.32e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AKT1—Alzheimer's disease	3.21e-06	3.03e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.11e-06	2e-05	CbGpPWpGaD
